201
Views
15
CrossRef citations to date
0
Altmetric
Research Article

Molecular mechanisms of Nano-selenium in mitigating hepatocellular carcinoma induced by N-nitrosodiethylamine (NDEA) in rats

, &
Pages 593-602 | Received 26 May 2014, Accepted 16 Aug 2014, Published online: 04 Sep 2014

References

  • Abdallah IZ, Khattab HA. (2004). Protective role of lycopene against diethylnitrosamine induced experimental hepatocarcinogenesis. Egypt J Hosp Med 16:1–13
  • Aggarwal BB, Sung B. (2011). NF-κB in cancer: a matter of life and death. Cancer Discov 1:469–71
  • A.O.A.C. (1995). Official methods of analysis. 16th ed. Wahington DC: Association of official analysis
  • Bai Y, Qin BY, Zhou YH, et al. (2011). Preparation and antioxidant capacity of element selenium nanoparticles sol–gel compounds. Nanosci Nanotechnol 11:5012–17
  • Banchroft JD, Stevens A, Turner DR. (1996). Theory and practice of histological techniques. 4th ed. New York, London, San Francisco, Tokyo: Churchil Livingstone
  • Barnes JM, Paget GE. (1965). Mechanisms of toxic action. Prog Med Chem 4:18–38
  • Bishayee A. (2012). Editorial: recent advances in the prevention and therapy of hepatocellular carcinoma. Curr Cancer Drug Targets 12:1043–4
  • Chen TF, Wong YS. (2009). Selenocysteine induces reactive oxygen species-mediated apoptosis in human cancer cells. Biomed Pharmacother 63:105–13
  • Chen TF, Wong YS, Zheng WJ, et al. (2008). Selenium nanoparticles fabricated in Undaria pinnatifida polysaccharide solutions induce mitochondria-mediated apoptosis in A375 human melanoma cells. Colloids Surf B 67:26–31
  • Combs GF. (2005). Current evidence and research needs to support a health claim for selenium and cancer prevention. J Nutr 135:343–7
  • Czene S, Testa E, Nygren J, et al. (2002). DNA fragmentation and morphological changes in apoptotic human lymphocytes. Biochem Biophys Res Commun 294:872–8
  • Darwish HA, El-Boghdady NA. (2011). Possible involvement of oxidative stress in diethylnitrosamine induced hepatocarcinogenesis: chemopreventive effect of curcumin. J Food Biochem 37:353–61
  • Denard B, Lee C, Ye J. (2012). Doxorubicin blocks proliferation of cancer cells through proteolytic activation of CREB3L1. eLife 1:e00090. 1–14
  • El-Bayoumy K, Sinha R. (2005). Molecular chemoprevention by selenium: a genomic approach. Mutat Res 591:224–36
  • El Mesallamy HO, Metwally NS, Soliman MS, et al. (2011). The chemopreventive effect of Ginkgo biloba and Silybum marianum extracts on hepatocarcinogenesis in rats. Cancer Cell Int 31;11:38–50
  • El-Nady GM, Ling R, Harrison TJ. (2003). Gene expression in HCV associated hepatocellular carcinoma-upregulation of a gene encoding a protein related to the ubiquitin-conjugating enzyme. Liver Int 23:329–37
  • El-Sayyad H, Ismail MF. Shalaby FM, et al. (2009). Histopathological effects of cisplatin, doxorubicin and 5-flurouracil (5-FU) on the liver of male albino rats. Int J Biol Sci 5:466–73
  • El-Serag HB. (2002). Hepatocellular carcinoma: an epidemiologic view. J Clin Gastroentero 35:S72–8
  • El-Zayadi A, Abaza H, Shawky S, et al. (2001). Prevalence and epidemiological features of hepatocellular carcinoma in Egypt – a single center experience. Hepatol Res 19:170–9
  • Geillinger KE, Rathmann D, Köhrle J, et al. (2014). Hepatic metabolite profiles in mice with a suboptimal selenium status. J Nutr Biochem 25:914–22
  • Gewirtz DA. (1999). A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin. Biochem Pharmacol 57:727–41
  • Heintges T, Wands JR. (1997). Hepatitis C virus: epidemiology and transmission. Hepatology 26:521–6
  • Karimov KY, Inoyatova FK, Mukhamedova MT. (2003). Changes in some indices of the synthesis of nitric oxide during the early stages of hepatocarcinogenesis. Exp Toxicol Pathol 55:17–9
  • Khalil WK, Booles HF. (2011). Protective role of selenium against over-expression of cancer-related apoptotic genes induced by O-cresol in rats. Arh Hig Rada Toksikol 62:121–9
  • Liang TJ, Rustgi V, Galun E, Blum HE. (1993). Viral pathogenesis of hepatocellular carcinoma in the United States. Hepatology 18:1326–33
  • Luo H, Wang F, Bai Y, et al. (2012). Selenium nanoparticles inhibit the growth of HeLa and MDA-MB-231 cells through induction of S phase arrest. Colloids Surf Biointerfaces 94:304–8
  • Nishinaka T, Miura T, Okumura M, et al. (2011). Regulation of aldo-keto reductase AKR1B10 gene expression: involvement of transcription factor Nrf2. Chem Biol Interact 2011;191:185–91
  • Patel M, Liang LP, Roberts LJ. (2001). Enhanced hippocampal F2-isoprostane formation following kainate induced seizures. J Neurochem 79:1065–9
  • Peng DG, Zhang JS, Liu QL, Taylor EW. (2007). Size effect of elemental selenium nanoparticles (Nano-Se) at supranutritional levels on selenium accumulation and glutathione S-transferase activity. J Inorg Biochem 101:1457–63
  • Pradeep K, Mohan CV, Gobianand K, Karthikeyan S. (2007). Silymarin modulates the oxidant-antioxidant imbalance during diethylnitrosamine induced oxidative stress in rats. Eur J Pharmacol 560:110–16
  • Purohit V, Russo D. (2002). Cellular and molecular mechanisms of alcoholic hepatitis. Alcohol 27:3–6
  • Rikiishi H. (2007). Apoptotic cellular events for selenium compounds involved in cancer prevention. J Bioenerg Biomembr 39:91–8
  • Seufi A, Safinz S, Ibrahim S, et al. (2009). Preventive effect of the flavonoid, quercetin, on hepatic cancer in rats via oxidant/antioxidant activity: molecular and histological evidences. J Exp Clin Canc Res 28:80–6
  • Seven A, Guzel S, Seymen O, et al. (2004). Effects of vitamin E supplementation on oxidative stress in streptozotocin induced diabetic rats: investigation of liver and plasma. Yonsei Med J 45:703–10
  • Tan L, Jia X, Jiang XF, et al. (2009). In vitro study on the individual and synergistic cytotoxicity of adriamycin and selenium nanoparticles against Bel7402 cells with a quartz crystal microbalance. Biosens Bioelectron 24:2268–72
  • Tawfeeq MM, Hayashi H, Shimamoto K, et al. (2012). Mechanistic study on liver tumor promoting effects of flutamide in rats. Arch Toxicol 86:497–507
  • Uthus E, Begaye A, Ross S, Zeng H. (2011). The von Hippel-Lindau (VHL) tumor-suppressor gene is down-regulated by selenium deficiency in Caco-2 cells and rat colon mucosa. Biol Trace Elem Res 142:223–31
  • Velazquez RE, Rodriguez M, Navascues CA, et al. (2003). Prospective analysis of risk factors for hepatocellular carcinoma in patients with liver cirrhosis. Hepatology 37:520–7
  • Verna L, Whysner J, Williams GM. (1996). N-Nitrodiethylamine mechanistic data and risk assessment: bioactivation, DNA-adduct formation, mutagenicity, and tumor initiation. Pharmacol Ther 71:57–81
  • Wang HL, Zhang JS, Yu HQ. (2007). Elemental selenium at nano size possesses lower toxicity without compromising the fundamental effect on selenoenzymes: comparison with selenomethionine in mice. Free Radic Biol Med 42:1524–33
  • Wong CM, Ng OL. (2008). Molecular pathogenesis of hepatocellular carcinoma. Liver Int 28:160–74
  • Yamaguchi F, Hirata Y, Akram H, et al. (2013). FOXO/TXNIP pathway is involved in the suppression of hepatocellular carcinoma growth by glutamate antagonist MK-801. BMC Cancer 13:468
  • Yim SH, Chung YJ. (2010). An overview of biomarkers and molecular signatures in HCC. A Cancers 2:809–23
  • Zhang JS, Gao XY, Zhang LD, Bao YP. (2001). Biological effects of a nano red elemental selenium. Biofactors 15:27–38
  • Zhang JS, Wang XF, Xu T. (2008). Elemental selenium at nano size (nano-Se) as a potential chemopreventive agent with reduced risk of selenium toxicity: comparison with Se-methylselenocysteine in mice. Toxicol Sci 101:22–31
  • Zhao R, Xiang N, Domann EF, Zhong WX. (2006). Expression of p53 enhances selenite-induced superoxide production and apoptosis in human prostate cancer cells. Cancer Res 66:2296–304
  • Zheng JS, Zheng SY, Zhang YB, et al. (2010). Sialic acid surface decoration enhances cellular uptake and apoptosis-inducing activity of selenium nanoparticles. Colloids Surf B 83:183–7
  • Zhou YP, Jia X, Tan L, et al. (2010). Magnetically enhanced cytotoxicity of paramagnetic selenium-ferroferric oxide nanocomposites on human osteoblast-like MG-63 cells. Biosens Bioelectron 25:1116–21

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.